MALIGNANT PLEURAL EFFUSION

Clinical trials for MALIGNANT PLEURAL EFFUSION explained in plain language.

Never miss a new study

Get alerted when new MALIGNANT PLEURAL EFFUSION trials appear

Sign up with your email to follow new studies for MALIGNANT PLEURAL EFFUSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2

New hope for easing cancer Patients' breathing struggles

Disease control Ongoing

This study is testing whether adding a drug called Endostar to standard cisplatin treatment works better than cisplatin alone for controlling malignant pleural effusion or ascites—painful fluid buildup in the chest or abdomen caused by cancer. It involves about 290 adults with ca…

Matched conditions: MALIGNANT PLEURAL EFFUSION

Phase: PHASE3 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Mar 19, 2026 14:55 UTC

MALIGNANT PLEURAL EFFUSION

Get alerted when new MALIGNANT PLEURAL EFFUSION trials appear

New hope for easing cancer Patients' breathing struggles